b
r
c
r
c
l
e
n
f
purpos
coronaviru
diseas
public
health
emerg
intern
concern
time
known
effect
pharmaceut
treatment
although
much
need
patient
contract
sever
form
diseas
aim
systemat
review
summar
evid
regard
chloroquin
treatment
method
pubm
embas
three
trial
registri
search
studi
use
chloroquin
patient
result
includ
six
articl
one
narr
letter
one
invitro
studi
one
editori
expert
consensu
paper
two
nation
guidelin
document
ongo
clinic
trial
china
chloroquin
seem
effect
limit
replic
viru
caus
vitro
conclus
rational
preclin
evid
effect
evid
safeti
longtim
clinic
use
indic
justifi
clinic
research
chloroquin
patient
howev
clinic
use
either
adher
monitor
emerg
use
unregist
intervent
meuri
framework
ethic
approv
trial
state
world
health
organ
safeti
data
data
highqual
clinic
trial
urgent
need
coronaviru
public
health
emerg
intern
concern
patient
contract
sever
form
diseas
constitut
approxim
case
time
known
specif
effect
proven
pharmacolog
treatment
invitro
studi
suggest
chloroquin
immunomodul
drug
tradit
use
treat
malaria
effect
reduc
viral
replic
infect
includ
sarsassoci
coronaviru
cov
merscov
chloroquin
use
worldwid
year
part
world
health
organ
model
list
essenti
medicin
also
cheap
establish
clinic
safeti
profil
howev
efficaci
safeti
chloroquin
treatment
new
viru
caus
pneumonia
remain
unclear
perform
systemat
review
pubm
embas
databas
incept
find
articl
provid
inform
efficaci
safeti
chloroquin
chloroquinerel
formul
patient
pneumonia
articl
describ
relat
invitro
studi
much
data
come
asia
languag
restrict
impos
see
detail
search
strategi
supplement
search
expand
use
snowbal
method
appli
refer
retriev
paper
also
search
chines
clinic
trial
registri
clinicatri
gov
intern
clinic
trial
registri
platform
ictrp
identifi
ongo
trial
two
author
ac
mi
independ
screen
databas
trial
registri
extract
relev
inform
mi
gi
discrep
doubt
relev
sourc
solv
consensu
two
author
ag
se
regist
systemat
review
protocol
anticip
limit
avail
evid
topic
due
urgenc
matter
journal
critic
care
xxx
xxx
initi
search
identifi
sourc
pubm
embas
sourc
follow
screen
titl
abstract
remov
duplic
evalu
eight
articl
full
text
among
found
six
relev
articl
one
narr
letter
one
research
letter
one
editori
one
expert
consensu
paper
chines
one
nation
guidelin
document
dutch
one
italian
twentythre
trial
found
trial
registri
tabl
research
letter
written
group
chines
research
studi
effect
chloroquin
vitro
use
vero
cell
infect
multipl
infect
moi
studi
demonstr
chloroquin
highli
effect
reduc
viral
replic
effect
concentr
ec
easili
achiev
standard
dose
due
favour
penetr
tissu
includ
lung
author
describ
chloroquin
known
block
viru
infect
increas
endosomi
ph
interf
glycosyl
cellular
receptor
sarscov
author
also
specul
possibl
known
immunomodul
effect
drug
may
enhanc
antivir
effect
vivo
narr
letter
chines
author
report
news
brief
state
council
china
indic
chloroquin
demonstr
mark
efficaci
accept
safeti
treat
associ
pneumonia
multicentr
clinic
trial
conduct
china
author
also
state
find
came
patient
includ
trial
sought
evid
data
trial
registri
review
found
none
editori
written
french
research
underlin
invitro
efficaci
chloroquin
viral
infect
especi
sar
whose
disappear
result
limit
research
also
discuss
potenti
favour
riskbenefit
balanc
high
safeti
low
expenditur
treatment
context
current
outbreak
sinc
case
report
countri
far
march
low
cost
chloroquin
major
benefit
highli
stress
healthcar
system
involv
highincom
countri
underfund
heathcar
system
middleand
lowincom
counti
expert
consensu
publish
februari
multicentr
collabor
group
depart
scienc
data
entri
use
definit
inform
provid
investig
trial
registri
avail
number
patient
popul
column
refer
report
sampl
size
primari
outcom
column
report
primari
outcom
describ
investig
bid
twice
per
day
rct
random
control
trial
technolog
guangdong
provinc
health
commiss
guangdong
provinc
paper
relat
specif
use
chloroquin
phosphat
inform
provid
method
use
achiev
consensu
base
vitro
evid
still
unpublish
clinic
experi
panel
recommend
chloroquin
phosphat
tablet
dose
mg
twice
per
day
day
patient
diagnos
mild
moder
sever
case
pneumonia
provid
contraind
drug
panel
recommend
use
sever
precaut
includ
blood
test
rule
develop
anemia
thrombocytopenia
leukopenia
well
serum
electrolyt
disturb
andor
hepat
renal
function
dysfunct
also
recommend
routin
electrocardiographi
rule
develop
qt
interv
prolong
bradycardia
patient
interview
seek
appear
visual
andor
mental
disturbancedeterior
panel
recommend
avoid
concurr
administr
drug
known
prolong
qt
interv
ie
chinolon
macrolid
ondansetron
well
variou
antiarrhythm
antidepress
antipsychot
drug
dutch
center
diseas
control
cdc
public
document
websit
suggest
treat
sever
infect
requir
admiss
hospit
oxygen
therapi
admit
icu
chloroquin
howev
document
also
state
treat
patient
optim
support
care
still
reason
option
due
lack
support
evid
suggest
regimen
adult
consist
mg
chloroquin
base
tablet
acq
mg
follow
mg
h
day
mg
per
os
day
day
document
also
underlin
need
stop
treatment
day
reduc
risk
side
effect
consid
long
halflif
drug
h
need
differenti
regimen
base
chloroquin
phosphat
chloroquin
base
sinc
mg
first
correspond
mg
second
anoth
guidelin
document
italian
societi
infecti
tropic
diseas
lombardi
section
recommend
use
chlorochin
mg
hydroxychloroquin
mg
die
day
although
treatment
may
vari
day
accord
clinic
sever
suggest
target
popul
rang
patient
mild
respiratori
symptom
comorbid
patient
sever
respiratori
failur
search
also
identifi
ongo
trial
china
tabl
trial
vari
studi
design
sever
diseas
target
popul
dose
durat
treatment
inde
trial
registr
vari
also
qualiti
report
inform
mani
studi
conduct
parallel
suggest
scientif
commun
make
huge
effort
clarifi
question
effort
probabl
insuffici
coordin
support
observ
chines
author
recent
issu
direct
regul
coordin
clinic
trial
studi
potenti
pharmacolog
treatment
result
trial
first
avail
human
sinc
studi
publish
date
characterist
manag
patient
report
data
chloroquin
use
note
publish
gener
protocol
random
clinic
trial
investig
clinic
efficaci
safeti
drug
hospit
patient
ie
master
templat
research
drug
set
vital
ethic
issu
whether
administr
chloroquin
set
experiment
therefor
requir
ethic
trial
approv
offlabel
ie
ethic
justifi
best
avail
treatment
addit
inform
chloroquin
soon
releas
context
evolv
outbreak
time
releas
inform
import
due
grow
number
infect
patient
absenc
licens
specif
drug
meanwhil
recommend
clinic
manag
sever
acut
respiratori
infect
novel
coronaviru
infect
suspect
publish
confirm
current
evid
rct
inform
specif
drug
treatment
unlicens
treatment
administ
context
ethicallyapprov
clinic
trial
monitor
emerg
use
unregist
intervent
framework
meuri
strict
monitor
therefor
seem
view
chloroquin
experiment
author
tend
agre
viewpoint
even
offlabel
use
chloroquin
may
accompani
sever
concern
first
patient
safeti
use
accompani
close
monitor
epidem
hardli
ideal
set
ethic
approach
offlabel
drug
use
also
differ
countri
rais
question
regard
equiti
final
chloroquin
remain
pivot
drug
treatment
malaria
mani
place
world
label
drug
use
creat
major
drug
shortag
suffici
preclin
rational
evid
regard
effect
chloroquin
treatment
well
evid
safeti
longtim
use
clinic
practic
indic
justifi
clinic
research
topic
current
circumst
justifi
priorit
ethic
review
studi
propos
less
press
research
topic
ie
fast
track
institut
ethic
review
although
use
chloroquin
may
support
expert
opinion
clinic
use
drug
patient
adher
meuri
framework
ethic
approv
trial
state
data
highqual
coordin
clinic
trial
come
differ
locat
worldwid
urgent
need
ac
conceiv
content
retriev
data
wrote
manuscript
approv
final
version
mi
retriev
data
wrote
manuscript
approv
final
version
gi
retriev
data
wrote
manuscript
approv
final
version
ag
conceiv
content
help
data
extract
revis
manuscript
critic
approv
final
version
se
conceiv
content
help
data
extract
wrote
manuscript
approv
final
version
none
ac
gi
mi
ag
se
declar
compet
interest
